can glp 1 cause acid reflux & Semaglutide GLP-1 and GIP-1 receptor agonists

Do not gamble with timing

Individual results may vary, and not all treatments are suitable for every person

Key approved indications include: Type 2 diabetes mellitus management (Mounjaro) Chronic weight management in obesity or overweight with comorbidities (Zepbound) Use as adjunct to lifestyle modification (diet and exercise) It is critical to recognize that tirzepatide has no FDA approval for the treatment, prevention, or management of autoimmune diseases

At this stage, GLP-1s are not considered first-line treatments for conditions outside of diabetes and obesity, but research in these areas is ongoing

Report any new or worsening mood changes promptly

STRIDE: Effects of Semaglutide on Functional Capacity in Patients With Type 2 Diabetes and Peripheral Arterial Disease